Vis enkel innførsel

dc.contributor.authorJohannessen, Charles
dc.contributor.authorMoi, Line
dc.contributor.authorKiselev, Yury
dc.contributor.authorPedersen, Mona Irene
dc.contributor.authorDalen, Stig Manfred
dc.contributor.authorBraaten, Tonje
dc.contributor.authorBusund, Lill-Tove
dc.date.accessioned2017-11-07T09:52:29Z
dc.date.accessioned2018-01-11T10:03:35Z
dc.date.available2017-11-07T09:52:29Z
dc.date.available2018-01-11T10:03:35Z
dc.date.issued2017
dc.identifier.citationJohannessen C, Moi LLH, Kiselev Y, Pedersen MI, Dalen SM, Braaten T, Busund LTRB. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. PLoS ONE. 2017;10:e0186658en
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/10642/5464
dc.description.abstractMicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional regulators of gene expression and are dysregulated in cancer. Studies of miRNAs to explore their potential as diagnostic and prognostic markers are of great scientific interest. Here, we investigate the functional properties and expression of the miR-143/145 cluster in breast cancer (BC) in vitro and in vivo. The ER positive MCF7, the HER2 positive SK-BR-3, and the triple negative cell line MDA-MB-231 were used to assess cell proliferation and cell invasion. Expression of miRNA in 108 breast cancers in the Norwegian Women and Cancer Study and 44 benign tissue controls were analyzed by microarray and validated by RT-PCR. Further, in situ hybridization (ISH) was used to study the cellular and subcellular distribution of the miRNAs. In vitro, miR-143 promoted proliferation of MCF7 and MDA-MB-231 cells, whereas miR-145 and the cotransfection of both miRNAs inhibited proliferation in all three cell lines. The cells’ invasive capacity was reduced after transfection and cotransfection of the miRNAs. In line with the tumor suppressive functions in vitro, the expression of miR-143 and miR-145 was lower in malignant compared to benign breast tissue, and lower in the more aggressive tumors with higher tumor grade, loss of ER and the basal-like phenotype. ISH revealed miR-143 to be cytoplasmatic and predominantly expressed in luminal cells in benign tissue, whilst miR-145 was nuclear and with strong staining in myoepithelial cells. Both miRNAs were present in malignant epithelial cells and stromal fibroblasts in BC. This study demonstrates that miR-143 and -145 have functional properties and expression patterns typical for tumor suppressors, but the function is influenced by cellular factors such as cell type and miRNA cotransfection. Further, the nuclear functions of miR-145 should be explored for a more complete understanding of the complexity of miRNA regulation and function in BC.en
dc.language.isoenen
dc.rightsCopyright: © 2017 Johannessen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectBreast canceren
dc.subjectMicroRNAs (miRNAs)en
dc.subjectMiR-143en
dc.subjectmiR-145en
dc.titleExpression and function of the miR-143/145 cluster in vitro and in vivo in human breast canceren
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2017-11-07T09:52:29Z
dc.description.versionpublishedVersionen
dc.identifier.doihttp://doi.org/10.1371/journal.pone.0186658
dc.identifier.cristin1509993
dc.source.journalPLoS ONE


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Copyright: © 2017 Johannessen et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Med mindre annet er angitt, så er denne innførselen lisensiert som Copyright: © 2017 Johannessen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.